Indicated in the investigation of a number of peroxisomal disorders where there is a defect in the metabolism or processing of long chain fatty acids. Patients may present with a spectrum of disease from life-threatening neonatal addisonian crises and severe hypotonia to progressive neurological deterioration and peripheral neuropathy in adults.
Working with our NHS service partners to set the standard for the future of pathology
Viapath is a founding member of The Association of Independent Pathology Providers (AIPP), which is a trade association representing innovative research-based diagnostic testing companies. www.pathologyassociation.com
Copyright 2014 Viapath Group LLP. Viapath, the Viapath logo and Nutris are registered trademarks of Viapath Group LLP.